Annual EBIT:
$10.43B+$1.95B(+22.91%)Summary
- As of today, AZN annual earnings before interest & taxes is $10.43 billion, with the most recent change of +$1.95 billion (+22.91%) on December 31, 2024.
- During the last 3 years, AZN annual EBIT has risen by +$9.42 billion (+931.95%).
- AZN annual EBIT is now -18.73% below its all-time high of $12.84 billion, reached on December 31, 2011.
Performance
AZN EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBIT:
$3.55B+$96.13M(+2.78%)Summary
- As of today, AZN quarterly earnings before interest & taxes is $3.55 billion, with the most recent change of +$96.13 million (+2.78%) on September 30, 2025.
- Over the past year, AZN quarterly EBIT has increased by +$765.54 million (+27.48%).
- AZN quarterly EBIT is now -21.45% below its all-time high of $4.52 billion, reached on March 31, 1999.
Performance
AZN Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
$12.71B+$765.54M(+6.41%)Summary
- As of today, AZN TTM earnings before interest & taxes is $12.71 billion, with the most recent change of +$765.54 million (+6.41%) on September 30, 2025.
- Over the past year, AZN TTM EBIT has increased by +$2.55 billion (+25.11%).
- AZN TTM EBIT is now at all-time high.
Performance
AZN TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
AZN EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +22.9% | +27.5% | +25.1% |
| 3Y3 Years | +932.0% | +173.4% | +294.8% |
| 5Y5 Years | +253.7% | +222.9% | +220.3% |
AZN EBIT Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +932.0% | -3.5% | +193.3% | at high | +294.8% |
| 5Y | 5-Year | at high | +932.0% | -3.5% | +3651.5% | at high | +598.5% |
| All-Time | All-Time | -18.7% | +2280.2% | -21.4% | +173.5% | at high | +3112.3% |
AZN EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $3.55B(+2.8%) | $12.71B(+6.4%) |
| Jun 2025 | - | $3.46B(-6.2%) | $11.94B(+5.4%) |
| Mar 2025 | - | $3.68B(+82.5%) | $11.33B(+4.0%) |
| Dec 2024 | $10.43B(+22.9%) | $2.02B(-27.6%) | $10.89B(+7.2%) |
| Sep 2024 | - | $2.79B(-1.9%) | $10.16B(+8.3%) |
| Jun 2024 | - | $2.84B(-12.5%) | $9.38B(+12.5%) |
| Mar 2024 | - | $3.25B(+152.5%) | $8.33B(+12.2%) |
| Dec 2023 | $8.49B(+121.6%) | $1.28B(-36.0%) | $7.42B(+1.0%) |
| Sep 2023 | - | $2.01B(+11.9%) | $7.35B(+10.7%) |
| Jun 2023 | - | $1.79B(-23.2%) | $6.64B(+20.6%) |
| Mar 2023 | - | $2.34B(+92.9%) | $5.51B(+36.8%) |
| Dec 2022 | $3.83B(+278.9%) | $1.21B(-6.8%) | $4.03B(+25.1%) |
| Sep 2022 | - | $1.30B(+96.5%) | $3.22B(+76.9%) |
| Jun 2022 | - | $661.00M(-22.7%) | $1.82B(-18.3%) |
| Mar 2022 | - | $855.00M(+112.2%) | $2.23B(-30.9%) |
| Dec 2021 | $1.01B(-80.5%) | $403.00M(+503.0%) | $3.22B(-24.8%) |
| Sep 2021 | - | -$100.00M(-109.4%) | $4.29B(-21.9%) |
| Jun 2021 | - | $1.07B(-42.2%) | $5.49B(-3.3%) |
| Mar 2021 | - | $1.85B(+26.2%) | $5.67B(+14.2%) |
| Dec 2020 | $5.19B(+75.9%) | $1.47B(+33.3%) | $4.97B(+25.2%) |
| Sep 2020 | - | $1.10B(-12.4%) | $3.97B(+8.5%) |
| Jun 2020 | - | $1.25B(+9.6%) | $3.66B(+25.9%) |
| Mar 2020 | - | $1.15B(+145.2%) | $2.90B(+0.8%) |
| Dec 2019 | $2.95B(-12.2%) | $467.00M(-40.9%) | $2.88B(-23.1%) |
| Sep 2019 | - | $790.00M(+57.1%) | $3.75B(-2.4%) |
| Jun 2019 | - | $503.00M(-55.2%) | $3.84B(-6.6%) |
| Mar 2019 | - | $1.12B(-15.8%) | $4.11B(+24.2%) |
| Dec 2018 | $3.36B(-6.4%) | $1.33B(+51.2%) | $3.31B(+67.5%) |
| Sep 2018 | - | $881.00M(+13.7%) | $1.98B(-12.2%) |
| Jun 2018 | - | $775.00M(+140.7%) | $2.25B(+13.6%) |
| Mar 2018 | - | $322.00M(>+9900.0%) | $1.98B(-23.1%) |
| Dec 2017 | $3.59B(-27.1%) | -$2.00M(-100.2%) | $2.58B(-41.2%) |
| Sep 2017 | - | $1.16B(+128.5%) | $4.39B(-0.8%) |
| Jun 2017 | - | $506.00M(-44.8%) | $4.42B(+6.4%) |
| Mar 2017 | - | $917.00M(-49.3%) | $4.16B(-5.0%) |
| Dec 2016 | $4.92B(+19.7%) | $1.81B(+51.6%) | $4.38B(+23.0%) |
| Sep 2016 | - | $1.19B(+394.6%) | $3.56B(+7.9%) |
| Jun 2016 | - | $241.00M(-78.8%) | $3.30B(-17.9%) |
| Mar 2016 | - | $1.14B(+15.1%) | $4.02B(+10.1%) |
| Dec 2015 | $4.11B(+86.0%) | $989.00M(+6.2%) | $3.65B(+50.2%) |
| Sep 2015 | - | $931.00M(-2.9%) | $2.43B(+4.9%) |
| Jun 2015 | - | $959.00M(+24.7%) | $2.32B(-12.3%) |
| Mar 2015 | - | $769.00M(+434.6%) | $2.64B(-13.9%) |
| Dec 2014 | $2.21B(-41.2%) | -$229.83M(-128.1%) | $3.07B(-37.1%) |
| Sep 2014 | - | $818.00M(-36.3%) | $4.88B(-15.9%) |
| Jun 2014 | - | $1.28B(+7.4%) | $5.80B(-0.3%) |
| Mar 2014 | - | $1.20B(-24.4%) | $5.82B(-4.8%) |
| Dec 2013 | $3.76B(-54.0%) | $1.58B(-8.9%) | $6.11B(-8.5%) |
| Sep 2013 | - | $1.74B(+33.6%) | $6.68B(-3.8%) |
| Jun 2013 | - | $1.30B(-12.5%) | $6.94B(-7.9%) |
| Mar 2013 | - | $1.49B(-30.9%) | $7.54B(-7.7%) |
| Dec 2012 | $8.16B(-36.4%) | $2.15B(+7.6%) | $8.17B(-2.8%) |
| Sep 2012 | - | $2.00B(+5.5%) | $8.40B(-7.6%) |
| Jun 2012 | - | $1.90B(-10.5%) | $9.09B(-10.2%) |
| Mar 2012 | - | $2.12B(-11.1%) | $10.12B(-10.9%) |
| Dec 2011 | $12.84B(+7.0%) | $2.38B(-11.6%) | $11.36B(-8.3%) |
| Sep 2011 | - | $2.70B(-7.9%) | $12.39B(+4.1%) |
| Jun 2011 | - | $2.93B(-12.9%) | $11.90B(-0.0%) |
| Mar 2011 | - | $3.36B(-1.4%) | $11.91B(+0.2%) |
| Dec 2010 | $12.00B(+1.2%) | $3.41B(+54.1%) | $11.88B(+6.4%) |
| Sep 2010 | - | $2.21B(-24.5%) | $11.16B(-8.6%) |
| Jun 2010 | - | $2.93B(-12.1%) | $12.21B(+2.2%) |
| Mar 2010 | - | $3.33B(+23.9%) | $11.95B(+3.2%) |
| Dec 2009 | $11.86B(+18.6%) | $2.69B(-17.4%) | $11.58B(+6.6%) |
| Sep 2009 | - | $3.26B(+22.0%) | $10.86B(+8.5%) |
| Jun 2009 | - | $2.67B(-10.0%) | $10.01B(+3.8%) |
| Mar 2009 | - | $2.97B(+50.7%) | $9.64B(+9.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2008 | $10.00B(+23.5%) | $1.97B(-18.2%) | $8.84B(+0.9%) |
| Sep 2008 | - | $2.41B(+4.6%) | $8.76B(+6.6%) |
| Jun 2008 | - | $2.30B(+6.6%) | $8.22B(+5.0%) |
| Mar 2008 | - | $2.16B(+14.3%) | $7.83B(+0.6%) |
| Dec 2007 | $8.09B(-1.5%) | $1.89B(+1.4%) | $7.78B(+0.1%) |
| Sep 2007 | - | $1.86B(-2.6%) | $7.77B(-1.5%) |
| Jun 2007 | - | $1.91B(-9.5%) | $7.89B(+0.0%) |
| Mar 2007 | - | $2.11B(+12.4%) | $7.89B(+2.9%) |
| Dec 2006 | $8.22B(+26.4%) | $1.88B(-5.1%) | $7.67B(+4.3%) |
| Sep 2006 | - | $1.98B(+3.7%) | $7.35B(+5.5%) |
| Jun 2006 | - | $1.91B(+1.0%) | $6.97B(+3.6%) |
| Mar 2006 | - | $1.89B(+20.8%) | $6.73B(+7.2%) |
| Dec 2005 | $6.50B(+43.0%) | $1.57B(-1.9%) | $6.27B(+5.9%) |
| Sep 2005 | - | $1.60B(-4.4%) | $5.93B(+8.0%) |
| Jun 2005 | - | $1.67B(+16.1%) | $5.49B(+14.6%) |
| Mar 2005 | - | $1.44B(+18.1%) | $4.79B(+7.8%) |
| Dec 2004 | $4.55B(+13.5%) | $1.22B(+5.4%) | $4.44B(+10.9%) |
| Sep 2004 | - | $1.16B(+19.0%) | $4.00B(+3.2%) |
| Jun 2004 | - | $972.31M(-11.0%) | $3.88B(+3.1%) |
| Mar 2004 | - | $1.09B(+39.8%) | $3.76B(-5.5%) |
| Dec 2003 | $4.01B(+0.0%) | $781.00M(-24.4%) | $3.98B(-6.5%) |
| Sep 2003 | - | $1.03B(+20.8%) | $4.26B(+2.0%) |
| Jun 2003 | - | $855.80M(-34.7%) | $4.17B(+25.8%) |
| Mar 2003 | - | $1.31B(+24.2%) | $3.32B(+0.4%) |
| Dec 2002 | $4.01B(-3.6%) | $1.06B(+10.9%) | $3.30B(+0.9%) |
| Sep 2002 | - | $951.92M(>+9900.0%) | $3.27B(+1.1%) |
| Jun 2002 | - | $0.00(-100.0%) | $3.24B(-22.3%) |
| Mar 2002 | - | $1.30B(+26.4%) | $4.17B(+5.8%) |
| Dec 2001 | $4.16B(+4.4%) | $1.03B(+12.1%) | $3.94B(+13.6%) |
| Sep 2001 | - | $915.39M(-1.7%) | $3.47B(+2.6%) |
| Jun 2001 | - | $930.83M(-12.9%) | $3.38B(-5.6%) |
| Mar 2001 | - | $1.07B(+92.5%) | $3.58B(+3.7%) |
| Dec 2000 | $3.98B(+16.1%) | $555.00M(-32.9%) | $3.45B(+1.5%) |
| Sep 2000 | - | $826.77M(-26.9%) | $3.40B(-2.3%) |
| Jun 2000 | - | $1.13B(+20.3%) | $3.48B(+3.6%) |
| Mar 2000 | - | $940.03M(+86.5%) | $3.36B(-51.6%) |
| Dec 1999 | $3.43B(+41.3%) | $504.00M(-44.5%) | $6.94B(+332.0%) |
| Sep 1999 | - | $908.00M(-10.0%) | $1.61B(-47.0%) |
| Jun 1999 | - | $1.01B(-77.7%) | $3.03B(+12.0%) |
| Mar 1999 | - | $4.52B(+193.6%) | $2.71B(+350.0%) |
| Dec 1998 | $2.43B(+28.6%) | -$4.83B(-307.3%) | $601.10M(-41.2%) |
| Sep 1998 | - | $2.33B(+240.2%) | $1.02B(+29.2%) |
| Jun 1998 | - | $685.00M(-71.7%) | $791.55M(-66.9%) |
| Mar 1998 | - | $2.42B(+154.8%) | $2.39B(+5.9%) |
| Dec 1997 | $1.89B(+6.1%) | -$4.41B(-310.1%) | $2.26B(-40.9%) |
| Sep 1997 | - | $2.10B(-8.1%) | $3.82B(-5.3%) |
| Jun 1997 | - | $2.28B(0.0%) | $4.03B(+0.1%) |
| Mar 1997 | - | $2.28B(+180.2%) | $4.03B(+0.1%) |
| Dec 1996 | $1.78B(+69.1%) | -$2.85B(-223.1%) | $4.02B(+89.9%) |
| Sep 1996 | - | $2.31B(+1.5%) | $2.12B(+21.8%) |
| Jun 1996 | - | $2.28B(0.0%) | $1.74B(+1184.3%) |
| Mar 1996 | - | $2.28B(+147.9%) | -$160.41M(+62.0%) |
| Dec 1995 | $1.05B(-8.3%) | -$4.75B(-345.6%) | -$421.81M(-240.2%) |
| Sep 1995 | - | $1.94B(+411.0%) | $300.94M(+153.4%) |
| Jun 1995 | - | $378.70M(-81.2%) | $118.74M(-92.5%) |
| Mar 1995 | - | $2.02B(+150.1%) | $1.58B(+12.9%) |
| Dec 1994 | $1.15B(+0.8%) | -$4.03B(-329.9%) | $1.40B(-8.8%) |
| Sep 1994 | - | $1.75B(-4.6%) | $1.53B(+16.4%) |
| Jun 1994 | - | $1.84B(0.0%) | $1.32B(+7.2%) |
| Mar 1994 | - | $1.84B(+147.2%) | $1.23B(+7.8%) |
| Dec 1993 | $1.14B(+159.9%) | -$3.90B(-353.4%) | $1.14B(-77.4%) |
| Sep 1993 | - | $1.54B(-12.1%) | $5.03B(+44.0%) |
| Jun 1993 | - | $1.75B(0.0%) | $3.50B(+100.0%) |
| Mar 1993 | - | $1.75B | $1.75B |
| Dec 1992 | $438.32M(-68.4%) | - | - |
| Dec 1991 | $1.39B(+29.3%) | - | - |
| Dec 1990 | $1.07B | - | - |
FAQ
- What is AstraZeneca PLC annual earnings before interest & taxes?
- What is the all-time high annual EBIT for AstraZeneca PLC?
- What is AstraZeneca PLC annual EBIT year-on-year change?
- What is AstraZeneca PLC quarterly earnings before interest & taxes?
- What is the all-time high quarterly EBIT for AstraZeneca PLC?
- What is AstraZeneca PLC quarterly EBIT year-on-year change?
- What is AstraZeneca PLC TTM earnings before interest & taxes?
- What is the all-time high TTM EBIT for AstraZeneca PLC?
- What is AstraZeneca PLC TTM EBIT year-on-year change?
What is AstraZeneca PLC annual earnings before interest & taxes?
The current annual EBIT of AZN is $10.43B
What is the all-time high annual EBIT for AstraZeneca PLC?
AstraZeneca PLC all-time high annual earnings before interest & taxes is $12.84B
What is AstraZeneca PLC annual EBIT year-on-year change?
Over the past year, AZN annual earnings before interest & taxes has changed by +$1.95B (+22.91%)
What is AstraZeneca PLC quarterly earnings before interest & taxes?
The current quarterly EBIT of AZN is $3.55B
What is the all-time high quarterly EBIT for AstraZeneca PLC?
AstraZeneca PLC all-time high quarterly earnings before interest & taxes is $4.52B
What is AstraZeneca PLC quarterly EBIT year-on-year change?
Over the past year, AZN quarterly earnings before interest & taxes has changed by +$765.54M (+27.48%)
What is AstraZeneca PLC TTM earnings before interest & taxes?
The current TTM EBIT of AZN is $12.71B
What is the all-time high TTM EBIT for AstraZeneca PLC?
AstraZeneca PLC all-time high TTM earnings before interest & taxes is $12.71B
What is AstraZeneca PLC TTM EBIT year-on-year change?
Over the past year, AZN TTM earnings before interest & taxes has changed by +$2.55B (+25.11%)